Last month, one of Canada’s largest cannabis retailers, High Tide, thrust its way into the booming German medical cannabis market by acquiring a majority stake in Remexian Pharma GmbH in a deal worth over €27m.
Cantourage [stock_market_widget type=”chart” template=”line” assets=”HIGH.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Berlin-based medical cannabis company Cantourage saw sales exceed its own projections in 2024, with sales more than doubling on 2023.
‘The way is clear’ for Germany’s growing list of municipalities, universities and cannabis businesses to launch model research projects into adult-use cannabis.
Young US women are consuming more cannabis than men for the first time, according to recently published data from the US National Institute on Drug Abuse (NIDA).
High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to announce that it is taking yet another step to expand its international brand portfolio by entering into a definitive agreement pursuant to which High Tide…
High Tide has announced that it has successfully completed a restructuring of approximately $8.9 million of the company’s outstanding debt held by a key industry lender under a senior secured convertible debenture.
Aurora Cannabis reports $87 million loss, aims for positive free cash flow Aurora Cannabis’ financial woes have continued in the first quarter of 2023, with the Canadian cannabis giant posting increasing net losses despite a slight bump in revenues.
LEADING North American cannabis retailer High Tide has unveiled plans to establish a High Street footprint in the emerging adult-use German market.
In October, the cannabis industry reconvened in Las Vegas for the annual tradeshow – MJ Biz Con – put on by Marijuana Business Daily.
